|Venture Round, 10/12 |
MB Venture Partners
Spinal Restoration was formed to identify and develop new, early intervention, minimally invasive therapies for the treatment of chronic low back pain. The company’s first endeavor is the Biostat® System, a proprietary resorbable biologic compound and delivery system for the treatment of chronic disc pain. The new treatment specifically targets discogenic pain, which represents the single largest population of patients—an estimated four million adults—who suffer from chronic low back pain annually.